We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.18%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$325B
AUM Growth
-$10.8B
(-3.2%)
Cap. Flow
-$13.4B
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
22.35%
Holding
3,492
New
145
Increased
887
Reduced
2,282
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$899M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$895M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$597M |
| 4 |
Clarivate
CLVT
|
+$315M |
| 5 |
Mastercard
MA
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.03B |
| 2 |
Apple
AAPL
|
+$962M |
| 3 |
Intel
INTC
|
+$470M |
| 4 |
Microsoft
MSFT
|
+$449M |
| 5 |
Home Depot
HD
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.56% |
| 2 | Financials | 13.11% |
| 3 | Healthcare | 12.33% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2851
Core Laboratories
CLB
$521M
| $1.3M | ﹤0.01% |
46,937
-28,240
| -38% | -$860K |
|
|
SIEN
2852
DELISTED
Sientra, Inc.
SIEN
| $1.3M | ﹤0.01% |
21,929
+2,970
| +16% | +$203K |
|
|
JNCE
2853
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.3M | ﹤0.01% |
167,060
+11,299
| +7% | +$70K |
|
2854
Astronics
ATRO
$3.84B
| $1.3M | ﹤0.01% |
123,372
-4,276
| -3% | -$54.3K |
|
2855
Civista Bancshares
CIVB
$589M
| $1.3M | ﹤0.01% |
57,037
-1,709
| -3% | -$39.3K |
|
2856
PureCycle Technologies
PCT
$1.45B
| $1.3M | ﹤0.01% |
100,301
-13,642
| -12% | -$206K |
|
|
ONTF
2857
DELISTED
ON24
ONTF
| $1.29M | ﹤0.01% |
64,182
+29,718
| +86% | +$825K |
|
2858
Hooker Furnishings Corp
HOFT
$166M
| $1.29M | ﹤0.01% |
49,129
-2,356
| -5% | -$75.3K |
|
2859
Cytosorbents Corp
CTSO
$22.6M
| $1.29M | ﹤0.01% |
147,786
-4,279
| -3% | -$34.8K |
|
|
PCSB
2860
DELISTED
PCSB Financial Corporation
PCSB
| $1.29M | ﹤0.01% |
70,448
-2,505
| -3% | -$45.7K |
|
2861
Lindblad Expeditions
LIND
$2.22B
| $1.29M | ﹤0.01% |
93,152
-360
| -0.4% | -$5.06K |
|
|
ETNB
2862
DELISTED
89bio
ETNB
| $1.28M | ﹤0.01% |
60,292
+5,678
| +10% | +$104K |
|
|
ENDP
2863
DELISTED
Endo International plc
ENDP
| $1.28M | ﹤0.01% |
451,274
-675,910
| -60% | -$2.39M |
|
|
KRTX
2864
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.27M | ﹤0.01% |
72,023
-13,155
| -15% | -$1.52M |
|
2865
Tredegar Corp
TG
$310M
| $1.27M | ﹤0.01% |
100,305
-563
| -0.6% | -$7.22K |
|
|
AMNB
2866
DELISTED
American National Bankshares Inc
AMNB
| $1.27M | ﹤0.01% |
39,504
-3,484
| -8% | -$112K |
|
|
LONA
2867
LeonaBio Inc
LONA
$72.1M
| $1.27M | ﹤0.01% |
12,508
+1,094
| +10% | +$111K |
|
2868
Pure Cycle
PCYO
$261M
| $1.27M | ﹤0.01% |
94,054
+5,374
| +6% | +$77.8K |
|
2869
Scholar Rock
SRRK
$6.44B
| $1.27M | ﹤0.01% |
92,403
-2,854
| -3% | -$99.9K |
|
2870
SIGA Technologies
SIGA
$219M
| $1.26M | ﹤0.01% |
186,793
-91,362
| -33% | -$585K |
|
2871
Protagonist Therapeutics
PTGX
$9.44B
| $1.26M | ﹤0.01% |
163,086
-3,239
| -2% | -$138K |
|
|
RYZ
2872
Ryerson Holding Corp
RYZ
$1.46B
| $1.26M | ﹤0.01% |
57,874
-1,624
| -3% | -$31.8K |
|
|
MSON
2873
DELISTED
Misonix Inc
MSON
| $1.26M | ﹤0.01% |
49,667
-1,234
| -2% | -$30.5K |
|
2874
Theravance Biopharma
TBPH
$877M
| $1.26M | ﹤0.01% |
176,717
-10,955
| -6% | -$123K |
|
|
EBTC
2875
DELISTED
Enterprise Bancorp
EBTC
| $1.25M | ﹤0.01% |
38,090
-1,548
| -4% | -$51.8K |
|
Similar funds
VFT
Nuveen's Q3 2021 Portfolio in Review
As of Q3 2021, Nuveen held 3,492 positions worth $325B, down 3.2% from $335B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen withdrew a net $13.4B in Q3 2021, closing 80 positions and reducing 2,282 holdings. Its most notable exit was Slack Technologies, Inc., an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Nuveen opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $596M.
- Nuveen's largest Q3 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 6,810,000 shares worth $596M.
- Nuveen added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q3 2021, an estimated $899M increase.
- Nuveen's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $1.03B.
- Nuveen fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $219M.
- Nuveen's ten largest holdings make up 22% of its $325B portfolio in Q3 2021.
- Nuveen opened 145 new positions and closed 80 in Q3 2021.
- Nuveen's portfolio value fell 3.2% quarter-over-quarter to $325B.
Based on Nuveen's 13F filing for Q3 2021, filed 12 Nov 2021.